Cargando…
Infection and Risk of Parkinson’s Disease
Parkinson’s disease (PD) is thought to be caused by a combination of genetic and environmental factors. Bacterial or viral infection has been proposed as a potential risk factor, and there is supporting although not entirely consistent epidemiologic and basic science evidence to support its role. En...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990414/ https://www.ncbi.nlm.nih.gov/pubmed/33361610 http://dx.doi.org/10.3233/JPD-202279 |
_version_ | 1783669067820826624 |
---|---|
author | Smeyne, Richard J. Noyce, Alastair J. Byrne, Matthew Savica, Rodolfo Marras, Connie |
author_facet | Smeyne, Richard J. Noyce, Alastair J. Byrne, Matthew Savica, Rodolfo Marras, Connie |
author_sort | Smeyne, Richard J. |
collection | PubMed |
description | Parkinson’s disease (PD) is thought to be caused by a combination of genetic and environmental factors. Bacterial or viral infection has been proposed as a potential risk factor, and there is supporting although not entirely consistent epidemiologic and basic science evidence to support its role. Encephalitis caused by influenza has included parkinsonian features. Epidemiological evidence is most compelling for an association between PD and hepatitis C virus. Infection with Helicobacter pylori may be associated not only with PD risk but also response to levodopa. Rapidly evolving knowledge regarding the role of the microbiome also suggests a role of resident bacteria in PD risk. Biological plausibility for the role for infectious agents is supported by the known neurotropic effects of specific viruses, particular vulnerability of the substantia nigra and even the promotion of aggregation of alpha-synuclein. A common feature of implicated viruses appears to be production of high levels of cytokines and chemokines that can cross the blood-brain barrier leading to microglial activation and inflammation and ultimately neuronal cell death. Based on multiple avenues of evidence it appears likely that specific bacterial and particularly viral infections may increase vulnerability to PD. The implications of this for PD prevention requires attention and may be most relevant once preventive treatments for at-risk populations are developed. |
format | Online Article Text |
id | pubmed-7990414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79904142021-04-14 Infection and Risk of Parkinson’s Disease Smeyne, Richard J. Noyce, Alastair J. Byrne, Matthew Savica, Rodolfo Marras, Connie J Parkinsons Dis Review Parkinson’s disease (PD) is thought to be caused by a combination of genetic and environmental factors. Bacterial or viral infection has been proposed as a potential risk factor, and there is supporting although not entirely consistent epidemiologic and basic science evidence to support its role. Encephalitis caused by influenza has included parkinsonian features. Epidemiological evidence is most compelling for an association between PD and hepatitis C virus. Infection with Helicobacter pylori may be associated not only with PD risk but also response to levodopa. Rapidly evolving knowledge regarding the role of the microbiome also suggests a role of resident bacteria in PD risk. Biological plausibility for the role for infectious agents is supported by the known neurotropic effects of specific viruses, particular vulnerability of the substantia nigra and even the promotion of aggregation of alpha-synuclein. A common feature of implicated viruses appears to be production of high levels of cytokines and chemokines that can cross the blood-brain barrier leading to microglial activation and inflammation and ultimately neuronal cell death. Based on multiple avenues of evidence it appears likely that specific bacterial and particularly viral infections may increase vulnerability to PD. The implications of this for PD prevention requires attention and may be most relevant once preventive treatments for at-risk populations are developed. IOS Press 2021-02-02 /pmc/articles/PMC7990414/ /pubmed/33361610 http://dx.doi.org/10.3233/JPD-202279 Text en © 2021 – IOS Press. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Smeyne, Richard J. Noyce, Alastair J. Byrne, Matthew Savica, Rodolfo Marras, Connie Infection and Risk of Parkinson’s Disease |
title | Infection and Risk of Parkinson’s Disease |
title_full | Infection and Risk of Parkinson’s Disease |
title_fullStr | Infection and Risk of Parkinson’s Disease |
title_full_unstemmed | Infection and Risk of Parkinson’s Disease |
title_short | Infection and Risk of Parkinson’s Disease |
title_sort | infection and risk of parkinson’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990414/ https://www.ncbi.nlm.nih.gov/pubmed/33361610 http://dx.doi.org/10.3233/JPD-202279 |
work_keys_str_mv | AT smeynerichardj infectionandriskofparkinsonsdisease AT noycealastairj infectionandriskofparkinsonsdisease AT byrnematthew infectionandriskofparkinsonsdisease AT savicarodolfo infectionandriskofparkinsonsdisease AT marrasconnie infectionandriskofparkinsonsdisease |